Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
Farmers Insurance
Covington
Deloitte
Merck
Cerilliant
QuintilesIMS
McKinsey
Accenture

Generated: January 19, 2018

DrugPatentWatch Database Preview

Benztropine mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for benztropine mesylate and what is the scope of benztropine mesylate patent protection?

Benztropine mesylate
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Hikma Farmaceutica, Luitpold, Navinta Llc, Oak Pharms Akorn, Anda Repository, Aspen Global Inc, Epic Pharma Llc, Invagen Pharms, Lannett Holdings Inc, Leading Pharma Llc, Oxford Pharms, Pliva, Quantum Pharmics, Usl Pharma, Vintage, and Merck, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for benztropine mesylate. Thirty-three suppliers are listed for this compound.
Pharmacology for benztropine mesylate
Medical Subject Heading (MeSH) Categories for benztropine mesylate

US Patents and Regulatory Information for benztropine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leading Pharma Llc BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 090168-003 Nov 28, 2012 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 089212-001 Jun 14, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pliva BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 089058-001 Aug 10, 1988 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck COGENTIN benztropine mesylate TABLET;ORAL 009193-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Epic Pharma Llc BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 072266-001 Feb 27, 1989 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Navinta Llc BENZTROPINE MESYLATE benztropine mesylate INJECTABLE;INJECTION 091525-001 Feb 5, 2013 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hikma Farmaceutica BENZTROPINE MESYLATE benztropine mesylate INJECTABLE;INJECTION 090287-001 Aug 31, 2009 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anda Repository BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 081264-001 Jan 23, 1992 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 040103-001 Dec 12, 1996 AA RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Quantum Pharmics BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 088511-001 Jan 31, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Baxter
Argus Health
Moodys
Colorcon
Federal Trade Commission
McKesson
Fuji
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot